Article
P53 genotyping - an effective concept for molecular testing of head and neck cancer?
International journal of molecular medicine - 1 Sept 1999
Dahse R, Fiedler W, von Eggeling F, Schimmel B, Koscielny S, Beleites E, Claussen U, Ernst G
Abstract excerpt
P53 mutations are currently recognized as the most common genetic alteration in human tumors. The purpose of our study was to evaluate the significance and reliability of p53 genotyping in head and neck cancer as a possible marker permitting the prediction of tumor behavior and clinical outcome. P53 genotyping in our study refers to highly sensitive molecular screening in order to detect structural alterations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
